Ireland
--:--IST
Latest
Clinical Trials in France / NCT07757581
Active, not recruiting Not applicable

Customized Knee Arthroplasty With or Without Posterior Cruciate Ligament Retention: A CR-PS Approach

NCT07757581 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2024-03-07
Last updated
2026-08-11

Condition(s) studied

Knee ArthroplastyOsteoarthritis, Knee

Investigational drug(s) / intervention(s)

Implantation surgery for CR and PS knee-joint prostheses used in the orthopedic surgery department's routine practice

Implantation surgery for CR and PS knee-joint prostheses used in the orthopedic surgery department's routine practice: The approach, the need for posterior cruciate ligament or collateral ligament release, the need to change from a CR to a PS prosthesis and the duration of the procedure will be recorded on the data collection sheet with the implantation and measurement characteristics performed with the navigator: * HKA and initial and final flessums * Tibial cuts: thickness (max), slope, obliquity of cut * Femoral sections: distal and posterior thickness (max), mechanical femoral angle, rotation, femoral flessum, obliquity of cut. * Thickness of implanted polyethylene

Study summary

Background and Rationale:

Conventional mechanical implantation of total knee arthroplasty (TKA) aims to establish a lower-limb mechanical axis of 180°. Computer-assisted personalized implantation aims to restore a pre-arthritic alignment while respecting the soft-tissue envelope of the knee. Depending on design, TKA implants may either retain or sacrifice the posterior cruciate ligament (PCL). In mechanically implanted TKAs, functional outcomes of cruciate-retaining (CR) and posterior-stabilized (PS) designs are reported as comparable in the literature. However, these two designs have not been compared within a computer-assisted personalized implantation workflow. Objective and Hypothesis:

The objective of this randomized comparative study is to compare functional outcomes (patient-reported outcome measures - PROMs) at 24 months postoperatively following CR versus PS knee arthroplasty implanted with a personalized technique. The hypothesis is that there is no significant difference in functional outcomes between CR and PS prostheses implanted using a personalized technique. Study Design:

Single-center, open-label, randomized, two-arm parallel-group trial comparing a group of patients receiving a cruciate-retaining (CR) total knee prosthesis to a group receiving a posterior-stabilized (PS) total knee prosthesis.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient information provided and signed written informed consent obtained in duplicate * Male and female participants aged 18 years or older * Primary total knee arthroplasty for knee osteoarthritis performed in the orthopaedic surgery department Exclusion Criteria: * History of posterior cruciate ligament (PCL) rupture or prior ligamentoplasty * History of ipsilateral femur or tibia fracture * Coronal plane axial deviation greater than 15 degrees (HKA \< 165° or \> 195°) * Flexion contracture (flexum) greater than 15 degrees * Tibial slope greater than 10 degrees * Patient deprived of liberty by judicial or administrative decision * Patient not affiliated with or beneficiary of a national social security scheme * Patient unable to understand French * Patient whose place of residence is incompatible with close in-person follow-up consultations * Woman of childbearing potential not using effective contraception * Pregnant or breastfeeding woman * Adult patient unable or unfit to give informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Groupe hospitalier Diaconesses Croix Saint Simon Paris France

More Groupe Hospitalier Diaconesses Croix Saint-Simon trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07757581 on ClinicalTrials.gov ↗ ← All trials in France